» Authors » B L Shneider

B L Shneider

Explore the profile of B L Shneider including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 847
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Duncan S, Annunziato R, Dunphy C, LaPointe Rudow D, Shneider B, Shemesh E
Pediatr Transplant . 2017 Dec; 22(1). PMID: 29218760
Non-adherence to immunosuppressant medications is an important risk factor for graft dysfunction. To evaluate the effectiveness of adherence-enhancing interventions, we reviewed adherence intervention studies in solid organ transplant recipients (all...
2.
Shemesh E, Bucuvalas J, Anand R, Mazariegos G, Alonso E, Venick R, et al.
Am J Transplant . 2017 Mar; 17(10):2668-2678. PMID: 28321975
Nonadherence to immunosuppressant medications is a leading cause of poor long-term outcomes in transplant recipients. The Medication Level Variability Index (MLVI) provides a vehicle for transplant outcome risk-stratification through continuous...
3.
Shemesh E, Annunziato R, Shneider B, Dugan C, Warshaw J, Kerkar N, et al.
Pediatr Transplant . 2008 Apr; 12(3):316-23. PMID: 18435607
We describe results from a clinical program, which aimed at improving adherence to medications in children who had a liver transplant. We followed the medical outcomes of 23 children and...
4.
Magee J, Krishnan S, Benfield M, Hsu D, Shneider B
Am J Transplant . 2008 Mar; 8(4 Pt 2):935-45. PMID: 18336697
This article represents the sixth annual review of the current state of pediatric transplantation in the United States from the Scientific Registry of Transplant Recipients (SRTR). It presents updated trends,...
5.
Shemesh E, Shneider B, Emre S
Pediatr Transplant . 2008 Mar; 12(3):281-3. PMID: 18331535
No abstract available.
6.
Saland J, Emre S, Shneider B, Benchimol C, Ames S, Bromberg J, et al.
Am J Transplant . 2006 Aug; 6(8):1948-52. PMID: 16889549
A male child initially presented with atypical hemolytic uremic syndrome (HUS) at the age of 4 months and progressed within weeks to end stage renal disease (ESRD). At the age...
7.
Green M, Michaels M, Katz B, Burroughs M, Gerber D, Shneider B, et al.
Am J Transplant . 2006 Aug; 6(8):1906-12. PMID: 16889546
A randomized controlled trial of CMV-IVIG (cytomegalovirus-intravenous immunoglobulin) for prevention of Epstein Barr virus (EBV) posttransplant lymphoproliferative disease (PTLD) in pediatric liver transplantation (PLTx) recipients was begun in Pittsburgh and...
8.
Goto T, Holzinger F, Hagey L, Cerre C, Ton-Nu H, Schteingart C, et al.
J Lipid Res . 2003 Jun; 44(9):1643-51. PMID: 12810826
5alpha-Cyprinol sulfate was isolated from bile of the Asiatic carp, Cyprinus carpio. 5alpha-Cyprinol sulfate was surface active and formed micelles; its critical micellization concentration (CMC) in 0.15 M Na+ using...
9.
Norton K, Lee J, Kogan D, Glass R, Shneider B, Emre S
Pediatr Transplant . 2002 Jan; 5(6):410-8. PMID: 11765725
We reviewed the results of 50 magnetic resonance (MR) cholangiograms to evaluate their usefulness in directing clinical management in young patients after liver transplantation (LTx). Thirty-two patients underwent 50 MR...
10.
Burroughs M, Emre S, Moscona A, Shneider B
J Pediatr Gastroenterol Nutr . 2001 Nov; 33(4):445-9. PMID: 11698761
Background: Risk factors for the development of posttransplant lymphoproliferative disease (PTLD), a major cause of morbidity and mortality after pediatric liver transplantation, are primary Epstein-Barr virus (EBV) infection and intensity...